Aaron S. Kesselheim, MD, JD, MPH

Director

Aaron S. Kesselheim is a Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital. He is a primary care physician at the Phyllis Jen Center for Primary Care at Brigham and Women’s Hospital. Within the Division, Dr. Kesselheim created and helps lead the Program On Regulation, Therapeutics, And Law (PORTAL, www.PORTALresearch.org), an independent (non-industry-funded) interdisciplinary research center focusing on intersections among prescription drugs and medical devices, patient health outcomes, and regulatory practices and the law. Author of over 800 publications in the peer-reviewed medical and health policy literatures, Dr. Kesselheim was recognized as one of the top three most cited health law scholars in the United States in Web of Science, Westlaw, and Google Scholar. 

Dr. Kesselheim is a core faculty member at the HMS Center for Bioethics and serves as a Visiting Professor of Law at Yale Law School, where he teaches a yearly course on Food and Drug Administration Law and Policy, which is also offered at the Yale School of Public Health. He is the editor-in-chief of the Journal of Law, Medicine, and Ethics. In 2020, he was elected to the National Academy of Medicine.